Eris Lifesciences Ltd. | Large-cap | Healthcare
₹1,685.00
0.07%
| Eris Lifesciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 28.8B
Gross Profit 21.7B 75.20%
Operating Income 7.0B 24.37%
Net Income 3.7B 13.01%
EPS (Diluted) ₹25.81

Balance Sheet Metrics

Total Assets 70.3B
Total Liabilities 37.6B
Shareholders Equity 32.7B
Debt to Equity 1.15

Cash Flow Metrics

Operating Cash Flow 7.6B
Free Cash Flow 9.1B

Revenue & Profitability Trend

Eris Lifesciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 28.8B 19.9B 16.6B 13.3B 11.9B
Cost of Goods Sold 7.1B 3.9B 3.6B 2.6B 2.4B
Gross Profit 21.7B 16.0B 13.0B 10.7B 9.5B
Operating Expenses 6.6B 5.3B 4.4B 3.4B 3.1B
Operating Income 7.0B 5.0B 4.2B 4.3B 3.9B
Pre-tax Income 4.9B 4.3B 4.0B 4.4B 3.9B
Income Tax 1.1B 341.8M 304.8M 364.1M 393.6M
Net Income 3.7B 4.0B 3.7B 4.1B 3.6B
EPS (Diluted) ₹25.81 ₹28.79 ₹28.07 ₹29.88 ₹26.14

Income Statement Trend

Eris Lifesciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 12.2B 23.0B 7.6B 6.3B 4.7B
Non-Current Assets 58.1B 47.5B 29.0B 16.4B 13.7B
Total Assets 70.3B 70.5B 36.7B 22.7B 18.3B
Liabilities
Current Liabilities 13.8B 25.3B 4.4B 2.0B 1.7B
Non-Current Liabilities 23.8B 12.9B 10.0B 1.6B 914.3M
Total Liabilities 37.6B 38.3B 14.5B 3.6B 2.6B
Equity
Total Shareholders Equity 32.7B 32.2B 22.2B 19.1B 15.8B

Balance Sheet Composition

Eris Lifesciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 4.9B 4.3B 4.0B 4.4B 3.9B
Operating Cash Flow 7.6B 3.2B 2.4B 3.8B 4.0B
Investing Activities
Capital Expenditures -1.5B -1.3B -8.4B -1.2B -257.2M
Investing Cash Flow -841.5M -18.6B -10.1B -3.1B -3.2B
Financing Activities
Dividends Paid -1.0B - -999.1M -816.2M -746.8M
Financing Cash Flow -7.3B 14.6B 7.2B -293.5M -746.7M
Free Cash Flow 9.1B 3.6B -5.5B 2.6B 3.5B

Cash Flow Trend

Eris Lifesciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 62.90
Forward P/E 39.05
Price to Book 7.75
Price to Sales 7.69
PEG Ratio 39.05

Profitability Ratios

Profit Margin 12.22%
Operating Margin 24.93%
Return on Equity 11.54%
Return on Assets 6.23%

Financial Health

Current Ratio 0.88
Debt to Equity 75.74
Beta -0.01

Per Share Data

EPS (TTM) ₹25.86
Book Value per Share ₹209.88
Revenue per Share ₹211.54

Financial data is updated regularly. All figures are in the company's reporting currency.